/

ICGIncannex Healthcare

data caveat——

Companies/ICG

IH

ICGActiveTier 2

Incannex Healthcare

ASX ↗

Data HealthTrials1 of 2 active · stale enrollment

No cash data on fileFigures from ASX filings · not financial advice

[ VITALS ]

Cash on Hand

—

Runway

—

Market Cap

—

Burn Rate

—

Shares Outstanding

—

Pipeline Assets

0

ICG

No price data

Pipeline Assets (0)

science

No pipeline data

Quarterly Cash Flow

payments

No cash flow data

Capital Raises & Buybacks

show_chart

No capital raise or buyback data

Other ticker data

Insider activity, holders, grants, publications

expand ›

Director Options & Rights

Director

Outstanding

Ex. Price

Expiry

No option data entered yet

Clinical Trials(4)

2 activeClinicalTrials.gov ↗

Ph2Not Yet Recruiting

IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamideIHL-42X: 5 mg dronabinol + 125 mg acetazolamideIHL-42X: 7.5 mg dronabinol + 125 mg acetazolamide

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

Obstructive Sleep Apnea (OSA)

ENROL120

no manual snapshots — enter via record_enrollment.py

NCT07635563 ↗CT.gov

Start

2026-06

Primary end

2027-04

Ph2/PHASE3Active Not RecruitingEnrollment stale · 815d

IHL-42X Low DoseIHL-42X High DosePlacebo

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

Obstructive Sleep Apnea

RandomizedQuadruple Blind18 Years+

Primary endpoint Change in apnea-hypopnea index (AHI)

ENROL560

no manual snapshots — enter via record_enrollment.py

NCT06146101 ↗CT.gov

Start

2024-05

Primary end

2026-12

Announcements(0)

All announcements →

description

No announcements